As transgenic mice overexpressing HMGA1 develop aggressive T-ALL [205], the group by Di Cello et al. aimed to understand whether CDKN2A/2B genomic loss cooperates with HMGA1 in T-ALL development [65]. Here, CDKN2A is linked to acute lymphoblastic leukemia.